100 related articles for article (PubMed ID: 7687589)
1. Pharmacokinetics and biological responses after treatment of the rat R-1 rhabdomyosarcoma with methotrexate.
Kipp JB; Leyva A; van Gennip AH; Kal HB
Int J Cancer; 1993 Jul; 54(6):945-51. PubMed ID: 7687589
[TBL] [Abstract][Full Text] [Related]
2. Treatment of the rat R-1 rhabdomyosarcoma with methotrexate and radiation; effects of timing on cell survival and tumour growth delay.
Kipp JB; Kal HB; van Gennip AH; van Berkel AH
J Cancer Res Clin Oncol; 1993; 119(4):215-20. PubMed ID: 8423196
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the effectiveness of methotrexate for the treatment of solid tumours by application of local hyperthermia.
Schopman EM; Van Bree C; Kipp JB; Barendsen GW
Int J Hyperthermia; 1995; 11(4):561-73. PubMed ID: 7594809
[TBL] [Abstract][Full Text] [Related]
4. Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; van Baal JM; Schretlen ED; De Bruijn CH
Biochem Pharmacol; 1988 Jun; 37(12):2329-38. PubMed ID: 2455520
[TBL] [Abstract][Full Text] [Related]
5. Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; Van Baal JM; De Vaan GA
Biochem Pharmacol; 1986 Oct; 35(20):3557-64. PubMed ID: 2429668
[TBL] [Abstract][Full Text] [Related]
6. Cell population kinetics of the rhabdomyosarcoma R1H of the rat after single doses of X-rays.
Jung H; Krüger HJ; Brammer I; Zywietz F; Beck-Bornholdt HP
Int J Radiat Biol; 1990 Mar; 57(3):567-89. PubMed ID: 1968949
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of vinblastine in rat blood plasma and tumour tissue determined by a biological method using flow cytofluorimetry.
Kipp JB; Barendsen GW
Eur J Cancer Clin Oncol; 1981 Aug; 17(8):867-73. PubMed ID: 7198977
[No Abstract] [Full Text] [Related]
8. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro.
Fabre G; Goldman ID
Cancer Res; 1985 Jan; 45(1):80-5. PubMed ID: 2578101
[TBL] [Abstract][Full Text] [Related]
9. 31P NMR study of the impact of dietary manipulation on tumor metabolism and response to methotrexate.
Sijens PE; van Echteld CJ; Neijt JP; Schipper J; Dunki Jacobs PB; de Graaf PW; Seijkens D
NMR Biomed; 1989 Jun; 2(1):12-8. PubMed ID: 2641288
[TBL] [Abstract][Full Text] [Related]
10. The proliferative status and clonogenic capacity of tumour cells in a transplantable rhabdomyosarcoma of the rat before and after irradiation with 800 rad of X-rays.
Hermens AF; Barendsen GW
Cell Tissue Kinet; 1978 Jan; 11(1):83-100. PubMed ID: 624118
[No Abstract] [Full Text] [Related]
11. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
12. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
[TBL] [Abstract][Full Text] [Related]
13. Host cell cytotoxicity, cellular repopulation dynamics, and phase-specific cell survival in X-irradiated rat rhabdomyosarcoma tumors.
Tenforde TS; Kavanau KS; Afzal SM; Curtis SB
Radiat Res; 1990 Jul; 123(1):32-43. PubMed ID: 2371379
[TBL] [Abstract][Full Text] [Related]
14. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis.
Kassis AI; Kirichian AM; Wang K; Semnani ES; Adelstein SJ
Int J Radiat Biol; 2004; 80(11-12):941-6. PubMed ID: 15764406
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate cytotoxicity as related to irreversible S phase arrest in mouse L1210 leukemia cells.
Tsurusawa M; Niwa M; Katano N; Fujimoto T
Jpn J Cancer Res; 1990 Jan; 81(1):85-90. PubMed ID: 2108951
[TBL] [Abstract][Full Text] [Related]
17. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
18. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.
Braakhuis BJ; Jansen G; Noordhuis P; Kegel A; Peters GJ
Biochem Pharmacol; 1993 Dec; 46(12):2155-61. PubMed ID: 7506025
[TBL] [Abstract][Full Text] [Related]
19. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
20. Silibinin improves the cytotoxicity of methotrexate in chemo resistant human rhabdomyosarcoma cell lines.
Hussain SA; Marouf BH
Saudi Med J; 2013 Nov; 34(11):1145-50. PubMed ID: 24252892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
